Caption Management’s SpringWorks Therapeutics SWTX Stock Holding History

Caption Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-150,300	Closed	-$6.63M	–	1875
2025 Q1	$6.63M	Buy	+150,300	New	+$6.92M	0.06%	299
2022 Q3	–	Sell	-2,500	Closed	-$62K	–	1831
2022 Q2	$62K	Sell	2,500 -60,000	-96%	-$2.19M	﹤0.01%	1327
2022 Q1	$3.53M	Buy	+62,500	New	+$3.58M	0.04%	558

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's SWTX Position: Q2 2025 in Review

Caption Management sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 116,994 shares — an estimated $5.2M sold.

Caption Management first reported a position in SWTX in Q1 2022 and held it in 4 quarters. The position peaked at $5.16M in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

Caption Management reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
Caption Management sold 116,994 SpringWorks Therapeutics shares in Q2 2025, an estimated $5.2M.
Caption Management first reported a position in SpringWorks Therapeutics in Q1 2022 and held it in 4 quarters.
Caption Management's SpringWorks Therapeutics position peaked at $5.16M in Q1 2025.
222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.